184 related articles for article (PubMed ID: 10947870)
21. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle.
Gilde AJ; Van Bilsen M
Acta Physiol Scand; 2003 Aug; 178(4):425-34. PubMed ID: 12864748
[TBL] [Abstract][Full Text] [Related]
23. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.
Ferré P
Diabetes; 2004 Feb; 53 Suppl 1():S43-50. PubMed ID: 14749265
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
Schoonjans K; Martin G; Staels B; Auwerx J
Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor gamma, the ultimate liaison between fat and transcription.
Rocchi S; Auwerx J
Br J Nutr; 2000 Dec; 84 Suppl 2():S223-7. PubMed ID: 11242474
[TBL] [Abstract][Full Text] [Related]
27. [PPARs, cancer cells and inflammation].
Tomita K; Hanafusa T
Nihon Rinsho; 2000 Feb; 58(2):461-4. PubMed ID: 10707577
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARgamma2 in 3T3-L1 cells.
Masugi J; Tamori Y; Kasuga M
Biochem Biophys Res Commun; 1999 Oct; 264(1):93-9. PubMed ID: 10527847
[TBL] [Abstract][Full Text] [Related]
29. [Physiological function of peroxisome proliferator-activated receptor].
Yanase T
Fukuoka Igaku Zasshi; 1999 Dec; 90(12):443-7. PubMed ID: 10655664
[No Abstract] [Full Text] [Related]
30. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
Clay CE; Namen AM; Atsumi G; Trimboli AJ; Fonteh AN; High KP; Chilton FH
J Investig Med; 2001 Sep; 49(5):413-20. PubMed ID: 11523697
[TBL] [Abstract][Full Text] [Related]
31. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors.
Willson TM; Lehmann JM; Kliewer SA
Ann N Y Acad Sci; 1996 Dec; 804():276-83. PubMed ID: 8993550
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator activated receptors and obesity.
Kersten S
Eur J Pharmacol; 2002 Apr; 440(2-3):223-34. PubMed ID: 12007538
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis.
Vanden Heuvel JP
Toxicol Sci; 1999 Jan; 47(1):1-8. PubMed ID: 10048147
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
[TBL] [Abstract][Full Text] [Related]
35. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
36. Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.
Shu H; Wong B; Zhou G; Li Y; Berger J; Woods JW; Wright SD; Cai TQ
Biochem Biophys Res Commun; 2000 Jan; 267(1):345-9. PubMed ID: 10623622
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone: mechanism of action.
Smith U
Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
[TBL] [Abstract][Full Text] [Related]
38. Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.
Palakurthi SS; Aktas H; Grubissich LM; Mortensen RM; Halperin JA
Cancer Res; 2001 Aug; 61(16):6213-8. PubMed ID: 11507074
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptors as molecular targets for drug therapy.
Sridhar GR
J Assoc Physicians India; 2003 Jan; 51():49-52. PubMed ID: 12693455
[TBL] [Abstract][Full Text] [Related]
40. The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease.
Everett L; Galli A; Crabb D
Liver; 2000 Jun; 20(3):191-9. PubMed ID: 10902968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
